MOLINA HEALTHCARE INC (1MOH.MI) Forecast, Price Target & Analyst Ratings
BIT:1MOH • US60855R1005
125.1 EUR
+16.65 (+15.35%)
Last: Mar 3, 2026, 07:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MOLINA HEALTHCARE INC (1MOH.MI).
Forecast Snapshot
Consensus Price Target
€146.42
+ 17.04% Upside
Next Earnings Forecast
Release DateApr 21, 2026
PeriodQ1 / 2026
EPS Estimate$3.79
Revenue Estimate11.297B
ChartMill Buy Consensus
56.30%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
€146.42
Upside
+ 17.04%
From current price of €125.10 to mean target of €146.42, Based on 27 analyst forecasts
Low
€121.11
Median
€144.09
High
€189.72
Price Target Revisions
1 Month
0.00%
3 Months
-7.86%
Price Target Summary
27 Wall Street analysts provided a forecast for the next 12 months for 1MOH.MI. The average price target is 146.42 EUR. This implies a price increase of 17.04% is expected in the next year compared to the current price of 125.1.
The average price target has been revised downward by 7.86% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
56.30%
1MOH.MI was analyzed by 27 analysts. The buy percentage consensus is at 56. So analysts seem to be rather neutral about 1MOH.MI.
In the previous month the buy percentage consensus was at a similar level.
1MOH.MI was analyzed by 27 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
Release DateApr 21, 2026
PeriodQ1 / 2026
EPS Estimate$3.79
Revenue Estimate11.297B
Revenue Q2Q1.35%
EPS Q2Q-37.62%
Number of Analysts18
Next Earnings Revisions
Revenue (1 Month)
-3.22%
Revenue (3 Months)
-3.92%
EPS (1 Month)
-18.23%
EPS (3 Months)
-18.19%
Next Earnings Summary
1MOH.MI is expected to report earnings on 4/21/2026. The consensus EPS estimate for the next earnings is 3.79 EUR and the consensus revenue estimate is 11.30B EUR.
The next earnings revenue estimate has been revised downward by 3.92% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 34.072B 6.56% | 40.65B 19.31% | 45.426B 11.75% | 47.011B 3.49% | 50.833B 8.13% | 51.817B 1.94% | 53.802B 3.83% | 55.356B 2.89% | 58.85B 6.31% | 61.921B 5.22% | 65.389B 5.60% | |
| EBITDA YoY % growth | 1.785B 10.53% | 1.894B 6.11% | 976M -48.47% | 1.277B 30.84% | 1.403B 9.87% | N/A | 2.31B | 2.552B 10.48% | 2.347B -8.03% | 2.761B 17.64% | 2.927B 6.01% | |
| EBIT YoY % growth | 1.614B 12.16% | 1.708B 5.82% | 781M -54.27% | 1.029B 31.75% | 1.236B 20.12% | 1.829B 47.98% | 2.001B 9.40% | 1.985B -0.80% | 2.028B 2.17% | 2.427B 19.67% | 2.574B 6.06% | |
| Operating Margin | 4.74% | 4.20% | 1.72% | 2.19% | 2.43% | 3.53% | 3.72% | 3.59% | 3.45% | 3.92% | 3.94% | |
| EPS YoY % growth | 20.89 16.64% | 22.65 8.43% | 10.65 -52.98% | 13.90 30.54% | 16.33 17.48% | 24.96 52.80% | 26.99 8.15% | 28.42 5.28% | 32.32 13.74% | 41.20 27.47% | 43.89 6.55% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 3.79 -37.62% | 4.10 -25.14% | 3.01 63.86% | 2.06 174.82% | 5.17 36.22% | 4.69 14.37% | 3.78 25.21% | 3.04 47.64% |
| Revenue Q2Q % growth | 11.297B 1.35% | 11.824B 3.47% | 11.954B 4.16% | 11.734B 3.16% | 12.45B 10.21% | 12.59B 6.48% | 12.747B 6.63% | 12.393B 5.62% |
| EBITDA Q2Q % growth | 293.05M -39.33% | 359.55M -25.09% | 290.84M 0.99% | 216.7M 556.67% | 482.51M 64.65% | 389.19M 8.24% | 265.19M -8.82% | 209.48M -3.33% |
| EBIT Q2Q % growth | 262.05M -39.76% | 298.22M -20.26% | 227.65M 66.17% | 157.75M 197.38% | 454.51M 73.44% | 361.55M 21.24% | 237.44M 4.30% | 182.45M 15.66% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
32.83%
EPS Next 5 Year
21.69%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
4.72%
Revenue Next 5 Year
4.17%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
18.96%
MOLINA HEALTHCARE INC / 1MOH.MI Forecast FAQ
Can you provide the average price target for MOLINA HEALTHCARE INC stock?
27 analysts have analysed 1MOH.MI and the average price target is 146.42 EUR. This implies a price increase of 17.04% is expected in the next year compared to the current price of 125.1.
What is the next earnings date for 1MOH stock?
MOLINA HEALTHCARE INC (1MOH.MI) will report earnings on 2026-04-21, after the market close.
What are the consensus estimates for 1MOH stock next earnings?
The consensus EPS estimate for the next earnings of MOLINA HEALTHCARE INC (1MOH.MI) is 3.79 EUR and the consensus revenue estimate is 11.30B EUR.
What is the number of analysts for 1MOH stock?
The number of analysts covering MOLINA HEALTHCARE INC (1MOH.MI) is 27.